Amphastar Pharmaceuticals AMPH

Health care sectorNasdaq

Watch

Wall StreetInsidersPolitics and policyAll recordsCompany

• 1 insiders, a net sale of $103.5K in 90 daysFiled 09/23
• $103.5K of planned sales filed in 30 days · under 0.1% of the units outstandingFiled 09/21

Insider trades

Insider	Trade type	Traded	Filed	Shares	Price	Value	Holding change
WP William J. PetersCFO, EVP & TREASURER	Open-market sale10b5-1 plan	09/21	09/23	4,139 sh	$25.00	$103,475	−2.4%
RZ Rong ZhouSENIOR EVP, PRODUCTION CENTER	Open-market sale	25/12/17	25/12/18	9,787 sh	$26.20	$256,419.4	−6.6%
FP Floyd F. PetersenDirector	Open-market sale	25/12/12	25/12/15	2,426 sh	$25.92	$62,881.92	−3.3%
FP Floyd F. PetersenDirector	Open-market sale	25/12/11	25/12/15	1,737 sh	$25.69	$44,623.53	−2.3%
RP Richard K. PrinsDirector	Open-market sale	25/11/25	25/11/25	4,179 sh	$27.10	$113,250.9	−10.6%

All insider trades in Amphastar Pharmaceuticals

Planned sales

Insider	Company	Shares to sell	Planned value	Planned date	Filed
WP William J. PetersOfficer	Amphastar PharmaceuticalsAMPH10b5-1 plan	4,139 sh	$103,475	09/21	Filed 09/21
RZ Rong ZhouVice President	Amphastar PharmaceuticalsAMPH	13,187 sh	$290,114	09/01	Filed 09/01
FP Floyd F. PetersenDirector	Amphastar PharmaceuticalsAMPH	47,101 sh	$989,121	08/18	Filed 08/18
RP Richard K. PrinsDirector	Amphastar PharmaceuticalsAMPH	7,973 sh	$161,931.63	08/11	Filed 08/11
WP William J. PetersOfficer	Amphastar PharmaceuticalsAMPH10b5-1 plan	8,180 sh	$183,886.4	08/07	Filed 08/07
FP Floyd F. PetersenDirector	Amphastar PharmaceuticalsAMPH	4,163 sh	$333,040	25/12/11	Filed 25/12/11
FP Floyd F. PetersenDirector	Amphastar PharmaceuticalsAMPH	1,737 sh	$43,425	25/12/10	Filed 25/12/10
RZ Rong ZhouOfficer	Amphastar PharmaceuticalsAMPH	20,000 sh	$500,000	25/11/28	Filed 25/11/28
RP Richard K. PrinsDirector	Amphastar PharmaceuticalsAMPH	4,179 sh	$104,475	25/11/25	Filed 25/11/25
FP Floyd F. PetersenDirector	Amphastar PharmaceuticalsAMPH	16,679 sh	$441,836.72	25/11/13	Filed 25/11/13

All planned sales of Amphastar Pharmaceuticals

No member of Congress reported a trade in Amphastar Pharmaceuticals AMPH in the past 90 days. Insiders filed 0 purchases and 1 sale on the open market over the same period, a net sale of $103.5K.